-
Mashup Score: 13Personalizing Treatment Decisions for Locally Advanced Rectal Cancer to Balance Quality of Life, Function, and Cancer Control - 5 month(s) ago
There has been a dramatic transformation of care for patients with locally advanced rectal cancer. Experts review risk stratification and therapeutic approaches with the overarching goal to better balance disease control with long-term quality of life and function.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 17Podcast: Personalizing Locoregional Treatment for Breast Cancer - 5 month(s) ago
Dr. Dionisia Quiroga discusses emerging approaches to personalizing locoregional treatment for breast cancer with Drs. Walter Paul Weber and Charlote Coles, who share insights on tailoring axillary surgery, escalating lymphatic surgery, and implementing hypofractionated radiotherapy.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
đ@quirogad of @OSUCCC_James, Dr. Walter Paul Weber of @UniSpitalBasel & Dr. Charlotte Coles of @Cambridge_Uni discuss personalizing locoregional treatment for #BreastCancer on the #ASCODailyNews Podcast: https://t.co/UMIXhZphid #bcsm https://t.co/c8tsV6J2lS
-
-
Mashup Score: 1Medical Training in a Time of Political Divide: From the Summer of âRacial Awakeningâ to DEI Bans - 5 month(s) ago
National and local legislation can affect the quality of care delivered and the ability to train effectively in all aspects of health care; ultimately this can impact cancer outcomes or worsen disparities in access.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Oncologists1Tweet-
"As the country focuses on the 2024 presidential election, medical students and residents may also worry about how political change can affect their training." https://t.co/mAgNBTQH2y https://t.co/lBH7DmG50d
-
-
Mashup Score: 8Choosing Treatment After Osimertinib for Patients With EGFR-Mutated NSCLC With MET Amplification - 5 month(s) ago
In EGFR-mutated NSCLC, treatment with the TKI osimertinib has routinely demonstrated superior survival rates; however, resistance is inevitable.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
In pts w/ EGFR-mutated #NSCLC, if liquid biopsy shows METamp postâosimertinib Tx, would it be appropriate to consider combination amivantamab? @BenjaminBesseMD, @LodovicaZullo & @JordiRemon of @GustaveRoussy explore the answer for #ASCODailyNews: https://t.co/rX1IDapEGl #lcsn https://t.co/nP5BYHaW9Z
-
-
Mashup Score: 47Podcast: How Are Cancer Centers Navigating IV Fluid Shortages and the Devastation of Hurricane Season? - 5 month(s) ago
Dr. Merry Jennifer Markham and ASCO CMO Dr. Julie Gralow discuss the shortage of IV fluids and other challenges that have emerged from Hurricane Helene as high-risk areas brace for impact from another storm, Hurricane Milton. In a conversation with Dr. John Sweetenham, they highlight resources for oncologists and patients and stress the importance of crisis preparedness at cancer centers.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
As #HurricaneMilton approaches Florida - and we still have power! - I wanted to thank @ASCO Daily News for the opportunity to speak with Dr. @jrgralow & Dr. John Sweetenham about the impact of hurricanes on cancer centers and our patients. https://t.co/OLw2d3mmuW https://t.co/ZRoImwfWYH
-
-
Mashup Score: 47Podcast: How Are Cancer Centers Navigating IV Fluid Shortages and the Devastation of Hurricane Season? - 5 month(s) ago
Dr. Merry Jennifer Markham and ASCO CMO Dr. Julie Gralow discuss the shortage of IV fluids and other challenges that have emerged from Hurricane Helene as high-risk areas brace for impact from another storm, Hurricane Milton. In a conversation with Dr. John Sweetenham, they highlight resources for oncologists and patients and stress the importance of crisis preparedness at cancer centers.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
As #HurricaneMilton approaches Florida - and we still have power! - I wanted to thank @ASCO Daily News for the opportunity to speak with Dr. @jrgralow & Dr. John Sweetenham about the impact of hurricanes on cancer centers and our patients. https://t.co/OLw2d3mmuW https://t.co/ZRoImwfWYH
-
-
Mashup Score: 10âDrug Holidaysâ Are an Increasingly Common Clinical Question With No Straightforward Answer - 5 month(s) ago
An Education Session will address emerging data on immunotherapy drug holidays and offer best practices for counseling patients who request them.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
âDrug Holidaysâ Are an Increasingly Common Clinical Question With No Straightforward Answer https://t.co/Uk07DJ8qjE What do you usually do? #ASCO24
-
-
Mashup Score: 16Podcast: Key Takeaways From the 2024 ASCO Quality Care Symposium - 5 month(s) ago
Dr. Fumiko Chino and Dr. Raymond Osarogiagbon share highlights from the 2024 ASCO Quality Care Symposium, including patient perspectives and compelling research on topics like equity, supportive care, survivorship, and technology and innovation.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
đ@fumikochino of @MDAndersonNews and @ROsarogiagbon of @BaptistHealth discuss key takeaways from #ASCOQLTY24 on the latest episode of the #ASCODailyNews Podcast: https://t.co/Xwjj1zXZsR #OncTwitter https://t.co/24vwshz5gY
-
-
Mashup Score: 16Podcast: Key Takeaways From the 2024 ASCO Quality Care Symposium - 5 month(s) ago
Dr. Fumiko Chino and Dr. Raymond Osarogiagbon share highlights from the 2024 ASCO Quality Care Symposium, including patient perspectives and compelling research on topics like equity, supportive care, survivorship, and technology and innovation.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
đ@fumikochino of @MDAndersonNews and @ROsarogiagbon of @BaptistHealth discuss key takeaways from #ASCOQLTY24 on the latest episode of the #ASCODailyNews Podcast: https://t.co/Xwjj1zXZsR #OncTwitter https://t.co/24vwshz5gY
-
-
Mashup Score: 31Incorporating Maintenance Venetoclax After Venetoclax Plus Chemo for Richterâs Transformation in Transplant-Ineligible CLL - 5 month(s) ago
Maintenance venetoclax after induction therapy offers a potential strategy to manage Richterâs transformation in patients with CLL not suitable for allogeneic stem cell transplant. However, decisions about which therapy to pursue after initial treatment must be individualized based on patient characteristics and preferences.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Incorporating Maintenance Venetoclax After Venetoclax Plus Chemo for Richterâs Transformation in Transplant-Ineligible CLL https://t.co/ZrqyQXW0a0
-
There has been a dramatic transformation of care for pts w locally advanced #RectalCancer w overarching goal to better balance disease control w long-term #QoL & function. Experts discuss treatments, recent trial data: https://t.co/SJSwRLUVc3 @KrishanJethwa #GICSM #ASCODailyNews https://t.co/uVt1wgStRg